Cargando…

Epidemiology of chronic kidney disease: think (at least) twice!

The introduction of the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines has substantially contributed to the early detection of different stages of chronic kidney disease (CKD). Several recent studies from different parts of the world mention a CKD prevalence of between 8 and 13%. There...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delanaye, Pierre, Glassock, Richard J., De Broe, Marc E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Cardiovascular Disease and CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5466090/ https://www.ncbi.nlm.nih.gov/pubmed/28617483 http://dx.doi.org/10.1093/ckj/sfw154

Ejemplares similares

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

The impact of renal protection clinics on prescription of and adherence to cardioprotective drug therapy in chronic kidney disease patients
por: Lepeytre, Fanny, et al.
Publicado: (2017)

Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease
por: Gillis, Keith, et al.
Publicado: (2018)

Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa
por: Adeniyi, Aderemi B., et al.
Publicado: (2017)

Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
por: Schmidt, Insa M, et al.
Publicado: (2019)

Acceptability of a multilevel intervention to improve blood pressure control among patients with chronic kidney disease in a public health care delivery system
por: Strait, Adrienne, et al.
Publicado: (2018)

Patterns of progression of chronic kidney disease at later stages
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2018)

The metabolomic quest for a biomarker in chronic kidney disease
por: Davies, Robert
Publicado: (2018)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Frailty and chronic kidney disease: current evidence and continuing uncertainties
por: Nixon, Andrew C, et al.
Publicado: (2018)

Is polypharmacy an increasing burden in chronic kidney disease? The German experience
por: Parker, Kathrine, et al.
Publicado: (2019)

Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease
por: Hunt, Taylor V, et al.
Publicado: (2018)

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy
por: Brown, Stephanie A, et al.
Publicado: (2017)

Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients
por: Lai, Silvia, et al.
Publicado: (2018)

Circulating active von Willebrand factor levels are increased in chronic kidney disease and end-stage renal disease
por: van der Vorm, Lisa N, et al.
Publicado: (2019)

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease
por: Hameed, Mohammed Awais, et al.
Publicado: (2017)

Incorporating patient-reported symptom assessments into routine care for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2017)

Obesity and chronic kidney disease progression—the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1
por: Barbieri, Diego, et al.
Publicado: (2018)

A scheme based on ICD-10 diagnoses and drug prescriptions to stage chronic kidney disease severity in healthcare administrative records
por: Friberg, Leif, et al.
Publicado: (2018)

Non-steroidal anti-inflammatory drugs in chronic kidney disease: a systematic review of prescription practices and use in primary care
por: Lefebvre, Claire, et al.
Publicado: (2019)

Low lean tissue mass is an independent risk factor for mortality in patients with stages 4 and 5 non-dialysis chronic kidney disease
por: Vega, Almudena, et al.
Publicado: (2017)

Current trends in European renal epidemiology
por: Heaf, James
Publicado: (2017)

Approach to atherosclerotic renovascular disease: 2016
por: Daloul, Reem, et al.
Publicado: (2016)

Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases
por: Golbin, Léonard, et al.
Publicado: (2017)

Cardiovascular-renal complications and the possible role of plasminogen activator inhibitor: a review
por: D'Elia, John A., et al.
Publicado: (2016)

The relationship between kidney function and quality of life among community-dwelling adults varies by age and filtration marker
por: Canney, Mark, et al.
Publicado: (2018)

What do epidemiological studies tell us about chronic kidney disease of undetermined cause in Meso-America? A systematic review and meta-analysis
por: González-Quiroz, Marvin, et al.
Publicado: (2018)

Medication discrepancies in late-stage chronic kidney disease
por: Ibrahim, Jamil, et al.
Publicado: (2018)

Novel insights into parathyroid hormone: report of The Parathyroid Day in Chronic Kidney Disease
por: Ureña-Torres, Pablo A, et al.
Publicado: (2018)

2017 update on pain management in patients with chronic kidney disease
por: Pham, Phuong Chi, et al.
Publicado: (2017)

Satellite cell function, intramuscular inflammation and exercise in chronic kidney disease
por: O’Sullivan, Tom F, et al.
Publicado: (2018)

Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3
por: Bouma-de Krijger, Annet, et al.
Publicado: (2019)

Elderly patients with chronic kidney disease: do they really need referral to the nephrology clinic?
por: McClure, Mark, et al.
Publicado: (2017)

Adherence to medication in patients with chronic kidney disease: a systematic review of qualitative research
por: Mechta Nielsen, Trine, et al.
Publicado: (2018)

Chronic kidney disease: considerations for monitoring skeletal muscle health and prescribing resistance exercise
por: Gollie, Jared M, et al.
Publicado: (2018)

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study
por: Brigant, Benjamin, et al.
Publicado: (2017)

Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: impact of reference ranges and parathyroid hormone generation assays on the KDIGO guidelines
por: Cavalier, Etienne, et al.
Publicado: (2018)

The European Renal Association – European Dialysis and Transplant Association Registry Annual Report 2014: a summary
por: Pippias, Maria, et al.
Publicado: (2017)

Small steps towards the potential of ‘preventive’ treatment of early phosphate loading in chronic kidney disease patients
por: Bover, Jordi, et al.
Publicado: (2019)

Anticoagulant-related nephropathy: systematic review and meta-analysis
por: de Aquino Moura, Karolinny Borinelli, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_n3dkmp7hoj2fedj0f9cs7dro8f